CT of the liver and spleen with EOE-13: review of 225 examinations.

EOE-13 is an experimental liver-spleen-specific computed tomographic (CT) contrast agent developed at the National Institutes of Health. Experience with this agent in 225 clinical examinations is described. On average, use of EOE-13 increases the attenuation of normal liver by 32.5 H and that of normal spleen by 52.3 H. Tumors in these organs increase only 2.6 H, making them more easily detectable. Most of the iodine in EOE-13 appears to clear from the liver and spleen by 24 hr after injection. No deaths or permanent morbidity have been observed. The complication rate is 3.6%. EOE-13 is valuable for the detection of hepatic and splenic tumors.

[1]  R. Fisher,et al.  Use of Intravenous Liposoluble Contrast Material for the Examination of the Liver and Spleen in Lymphoma , 1981, Journal of computer assisted tomography.

[2]  G. Toniolo,et al.  Adverse reactions to contrast media: a report from the Committee on Safety of Contrast Media of the International Society of Radiology. , 1980, Radiology.

[3]  J. Bruel,et al.  The Use of Iodolipids in Hepatosplenic Computed Tomography , 1979, Journal of computer assisted tomography.

[4]  J A Hanley,et al.  If nothing goes wrong, is everything all right? Interpreting zero numerators. , 1983, JAMA.

[5]  R. Fisher,et al.  Clinical trials with a new intravenous liposoluble contrast material for computed tomography of the liver and spleen. , 1980, Radiology.

[6]  J. Doppman,et al.  Detection of hepatic metastases: comparison of EOE-13 computed tomography and scintigraphy. , 1983, AJR. American journal of roentgenology.

[7]  M. Adson,et al.  Surgical treatment of hepatic metastases from colorectal cancers. , 1976, Archives of surgery.

[8]  J. Gallelli,et al.  Formulation and evaluation of ethiodized oil emulsion for intravenous hepatography. , 1979, Journal of pharmaceutical sciences.

[9]  J. Dutcher,et al.  Ethiodized oil emulsion 13 in computed tomography of hepatoma. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  R. Fisher,et al.  EOE-13 in the detection of hepatosplenic lymphoma. , 1982, Radiology.

[11]  J. Doppman,et al.  Improved detection of focal lesions with computerized tomographic examination of the liver using ethiodized oil emulsion (EOE‐13) liver contrast , 1984 .

[12]  M. Adson.  Hepatic metastases in perspective. , 1983, AJR. American journal of roentgenology.

[13]  M. Bernardino,et al.  CT Detection of Hepatic Metastases with Ethiodized Oil Emulsion 13 , 1982, Journal of computer assisted tomography.

[14]  J. Doppman,et al.  Biodistribution Study of Ethiodized Oil Emulsion 13 for Computed Tomography of the Liver and Spleen , 1982, Journal of computer assisted tomography.

[15]  P. Sugarbaker,et al.  Rate of growth of intraabdominal metastases from colorectal cancer , 1984, Cancer.

[16]  H. Wanebo,et al.  Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. , 1978, American journal of surgery.

[17]  J. Doppman,et al.  Development and Experimental Evaluation of a Contrast Medium for Computed Tomographic Examination of the Liver and Spleen , 1979, Journal of computer assisted tomography.

[18]  J. Doppman,et al.  Intravenous hepatosplenography. Experiment evaluation of a new contrast material. , 1976, Radiology.

[19]  R. Fisher,et al.  Computed tomography of the liver and spleen with intravenous lipoid contrast material: review of 60 examinations. , 1982, AJR. American journal of roentgenology.

[20]  J. Doppman,et al.  Intra-arterial hepatography: experimental evaluation of a new contrast agent. , 1974, Radiology.